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Abstract In the eighties, iron regulatory protein-1 (IRP-1) was 
identified as a cytoplasmic mRNA-binding protein that regulates 
vertebrate cell iron metabolism. More recently, IRP-1 was found 
to represent he functional cytoplasmic homologue of mitochon- 
drial aconitase, a citric acid cycle enzyme. Its two functions are 
mutually exclusive and depend on the status of an Fe-S cluster: 
the (cluster-less) apoIRP-I binds to RNA, while the incorpora- 
tion of a cubane 4Fe-4S cluster is required for enzymatic activity. 
Cellular signals including iron levels, nitric oxide and oxidative 
stress can regulate between the two activities posttranslationally 
and reversibly via the Fe-S cluster. Recent reports suggest hat 
other regulatory proteins may be controlled by similar mechan- 
isms. 
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1. Introduction 
In recent years, a new class of bifunctional proteins made 
its appearance: enzymes that perform seemingly unrelated 
second functions as nucleic acid binding proteins. The list 
includes (amongst others) thymidylate synthase, dihydrofolate 
reductase, iron regulatory protein-l, glyceraldehyde-3-phos- 
phate dehydrogenase and glutamate dehydrogenase. The 
physiological role of RNA binding remains obscure or incom- 
pletely characterised for the majority of these proteins [1], 
with iron regulatory protein-1 (IRP-1) representing a notable 
exception: the interaction of IRP-1 with its target mRNAs 
regulates key aspects of cellular iron metabolism. Its second 
identity is that of cytoplasmic aconitase, converting citrate to 
isocitrate (for recent reviews see [2,3]). In this minireview, we 
will illustrate the two functions of IRP-1 and discuss the novel 
mechanism by which they are regulated. 
2. IRP-I: an RNA binding protein that regulates iron 
homeostasis 
IRP-1 (previously termed IRF, IRE-BP, FRP) is a 98 kDa 
cytoplasmic protein. It was first identified in mammalian cells 
as an RNA-binding protein that recognises a specific RNA 
hairpin motif, the iron-responsive element (IRE). An IRE is a 
30 nucleotide structure formed by two RNA helices that 
are separated by a bulged cytosine residue, and by a six-nu- 
cleotide loop of the sequence 5'CAGUGN3'  (N is usually a 
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pyrimidine). The sequence of the loop and the bulged nucleo- 
tide is conserved, as is the length of the RNA helix between 
the two (5 base pairs). 
Functional IREs have been identified in the 5' untranslated 
regions (UTR) of ferritin H-chain, ferritin L-chain, erythroid 
aminolevulinate synthase (eALAS), mitochondrial (mt)-aconi- 
tase and succinate dehydrogenase (SDH) mRNAs, as well as 
the 3' UTR of transferrin receptor (TfR) mRNA [2-11]. Bind- 
ing of IRP-1 to a single IRE in the 5' UTR inhibits transla- 
tion by preventing the stable association of the small riboso- 
mal subunit with the mRNA [12], probably by a steric 
mechanism that does not require additional co-factors or cel- 
lular proteins [13]. When it binds to the 3' UTR of TfR 
mRNA, IRP-1 stabilises the message by binding to five 
IREs [10,11]. The molecular mechanism underlying this pro- 
tection of TfR mRNA from degradation is complex and not 
yet well understood. 
IRP-I binds to IREs with high affinity when cellular iron 
levels are low. As a result, ferritin, eALAS, mt-aconitase and 
SDH synthesis is repressed, while TfR mRNA is stabilised. 
When cells are iron replete, the affinity of IRP-1 for IRE is 
drastically diminished [2,3]. Translational repression of the 
target mRNAs is relieved, while TfR mRNA is rapidly de- 
graded. In this way the expression of proteins involved in iron 
uptake (TfR), storage (ferritin) and utilisation (eALAS is the 
first enzyme in the heme biosynthetic pathway, mt-aconitase 
and SDH are iron containing enzymes) is co-ordinated by the 
regulation of the affinity of IRP-1 for its IRE binding sites. 
3. IRP-1 is a cytoplasmic aconitase 
Following the purification of IRP-1 and the cloning of its 
cDNA, computer-based comparisons of the deduced amino 
acid sequence revealed the homology between IRP-1 and mi- 
tochondrial aconitase [14,15]. Mitochondrial aconitase is a 
4Fe-4S cluster-containing protein which catalyses the conver- 
sion of citrate to isocitrate within the mitochondrial citric acid 
cycle. The two proteins display ,~31% identity and ~56% 
similarity along their entire length. A cytoplasmic homologue 
of mitochondrial conitase was long known to exist [16], but 
its role in cell metabolism was not well understood. Both IRP- 
1 and c-aconitase are known to be localised on human chro- 
mosome 9, and the homology between IRP-1 and mt-aconi- 
tase, particularly the 100% identity of amino acids involved in 
the formation of the enzyme's catalytic core, suggested the 
possibility that IRP-1 and cytoplasmic aconitase might repre- 
sent two forms of the same protein [14,15]. A number of 
studies have experimentally corroborated this hypothesis, 
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Fig. 1. Mitochondrial aconitase as a structural model for IRP-1, in its role as cytoplasmic aconitase (A) and IRE-binding protein (B). Based 
on the structure of mt-aconitase [25,26], two forms have been drawn without making allowances for differences between mt-aconitase and IRP- 
1. (A) In the 4Fe-4S cluster containing enzyme, domains 1-3 (coloured in green) and 4 (coloured in blue) form a narrow cleft (closed form), 
where the Fe-S cluster (Fe atoms coloured in blue, S atoms coloured in yellow) is found, linked to three cysteines (coloured in orange) of the 
protein backbone. The substrate, citrate (coloured in red), is situated within the cleft and interacts with both the cluster and the protein back- 
bone (R536, R541, R699, R780 coloured in magenta). In this conformation, the narrow cleft prohibits IRE binding. (B) The apoprotein form 
may adopt a more open conformation, via the hinge linker. Domains 1-3 and 4 may separate nough to accommodate he IRE (coloured in 
red). In this form, the IRE may contact amino acids 121-130 (coloured in magenta) and the region close to C437 (coloured in orange). The 
aconitase structure [25,26] is depicted using RIBBONS [49] and WHAT IF [50] for modeling. 
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demonstrating that purified cytosolic aconitase and purified 
as well as recombinant IRP-1 display IRE-binding and aco- 
nitase activity, and that the amino acid sequence of purified 
bovine cytosolic aconitase closely matches that of human 
IRP-1 [17-20]. 
cDNAs encoding a protein with ,'~ 60% identity and ,-~ 80% 
similarity to IRP-1 have also been cloned. This protein (IRP- 
2), which will not be discussed further here, is also an IRE- 
binding protein and thus participates in the control of cellular 
iron metabolism (for a review see [3]). The regulation of its 
RNA binding activity occurs by a different mechanism, and 
IRP-2 does not exhibit aconitase activity [21-27]. 
4. Switching between the two functions 
Much information is available concerning the biochemistry 
and structure of mt-aconitase [28-30]. Mt-aconitase is com- 
posed of four domains. The three N-terminal domains form a 
compact core, while the fourth domain is linked to this core 
by a flexible hinge (Fig. 1A). Domains 1-3 (coloured in green) 
and 4 (coloured in blue) form a narrow cleft between them, 
which leads to the active site of the enzyme. A cubane 4Fe-4S 
cluster (coloured in blue and yellow) is situated within this 
cleft, with three of the four Fe atoms linked to three cysteines 
of the protein backbone. The fourth Fe atom of the cluster 
can interact with the substrate, citrate (coloured in red). On 
the basis of the similarities in amino acid composition and 
enzymatic function, the structure of mt-aconitase may provide 
a suitable model for considering structural features of IRP-1. 
Three forms of IRP-1 can be purified from cells. The 4Fe- 
4S cluster containing protein is the predominant form within 
iron replete cells. It does not bind to IREs, binds citrate and 
displays aconitase activity. In addition to its interaction with 
the Fe of the cluster, citrate also interacts with four arginines 
(R536, R541, R699, R780 in the human IRP-1 sequence) 
which contributes to the stabilisation of the protein structure 
and narrowing of the cleft. Under these circumstances, the 
narrow cleft may prohibit IRE binding. Since a fully as- 
sembled cluster is required for enzymatic activity, a 3Fe-4S 
cluster containing IRP-1 (although able to bind citrate) is 
enzymatically inactive. In addition, the 3Fe-4S form of the 
protein exhibits no IRE binding activity, presumably because 
the Fe-S cluster (and citrate?) maintain the cleft in a closed 
state. It is not clear whether this 3Fe-4S form may represent a 
physiological intermediate in cluster disassembly of IRP-1. 
The apoprotein form of IRP-1 is the RNA binding form 
that is present in iron-starved cells. It shows no aconitase 
activity and little citrate binding. The lack of the cluster 
may allow IRP-1 to adopt a more open conformation between 
domains 1-3 and 4 which permits access and binding of the 
IRE, as suggested on the basis of the mt-aconitase structure 
depected in Fig. lB. 
Thus, the two functions of IRP-1 are mutually exclusive 
and regulated via the iron-sulphur cluster. Mutational anal- 
yses show that serine replacement of any of the three active 
site cysteine residues (C437, C503, C506) involved in cluster 
binding results in complete loss of aconitase activity and con- 
stitutive RNA binding [31]. Alkylation of C437 with a bulky 
compound (N-ethylmaleimide) causes loss of RNA binding, 
while alkylation with a smaller group (iodoacetamide) does 
not affect IRE binding [32]. When modeled according to the 
structure of mt-aconitase, C437 is not far from amino acids 
121-130, to which the IRE has been crosslinked using ultra- 
violet light [33]. Furthermore, three of the four arginines that 
participate in substrate binding (R536, R541, R780) may also 
contribute to RNA binding [34]. Taken together, these find- 
ings suggest hat the IRE binding site(s) is in close proximity 
to the catalytic enter of the protein, and that a significant 
rearrangement of the protein is required to permit access of 
the IRE to what would otherwise be hidden within the narrow 
cleft. Such a rearrangement may be the opening of the cleft 
via the flexible hinge linker, as suggested in Fig. lB. Unex- 
pectedly, multiple sequence alignment of several members of 
the Fe-S isomerase family has identified additional, highly 
conserved residues that were previously unrecognised. These 
amino acids could also prove to be important for the struc- 
tural/functional organisation of IRP-1 [35]. 
The molecular mechanisms by which 4Fe-4S cluster assem- 
bly and disassembly are achieved in response to cellular iron 
levels remain to be defined. It is not known whether these 
processes are 'spontaneous' or whether cellular factors facil- 
itate cluster formation and/or removal. Interestingly, the bac- 
terial protein NifS has been shown to be required for the in 
vivo formation of 4Fe-4S centers in nitrogenase [36] and to 
accelerate 2Fe-2S cluster formation in vitro in the E. coli 
transcription factor SoxR [37]. The role of NifS appears to 
be the mobilisation of inorganic sulphide from L-cysteine [38], 
and it is tempting to speculate that mammalian homologues 
of NifS may exist and be involved in iron regulation of IRP-1. 
Independently of iron, nitric oxide (NO) and hydrogen per- 
oxide (H202) regulate the aconitase and IRE-binding activ- 
ities of IRP-1 [3944]. Biochemical evidence suggests that NO 
and H202 also induce cluster emoval [42,43], but a definitive 
answer will require the application of more direct analytical 
methods. Although both are small, diffusible, reactive mole- 
cules, NO and H202 regulate IRP-1 via different pathways: 
while NO regulation is kinetically slow (as is iron regulation), 
H202-mediated activation of IRE binding occurs within 30 60 
min [45]. The regulation of IRP-1 by NO and H202 strongly 
suggests that iron-sulphur clusters can serve as regulatory 
modules in response to stress signals. This notion is corrobo- 
rated by the recent implication that iron-sulphur clusters may 
play a role in the stress regulation of two bacterial transcrip- 
tion factors, Fnr [46] and SoxR [47]. Thus, iron-sulphur clus- 
ters are beginning to emerge as a new class of switches uited 
to execute regulatory responses to stimuli such as NO, oxida- 
tive stress and oxygen tension. 
5. Why two functions? 
The role of iron regulated IRE-binding of IRP-1 for the 
homeostatic, posttranscriptional control of iron storage, up- 
take and utilisation is easily understandable. Less clear is the 
physiological role of IRP-1 as a cytoplasmic aconitase. Aco- 
nitase activity is not a necessary requirement for the regula- 
tion of IRE binding, because mutation of a critical serine 
($778) to an alanine causes apparent loss of catalytic activity 
without affecting iron regulation of IRE binding in vivo [34]. 
Recent results suggest hat the expression of mt-aconitase is 
translationally regulated by IRP-1 binding to an IRE in the 5' 
untranslated region of mt-aconitase mRNA [9]. Taken to- 
gether with the posttranslational regulation of cytosolic aco- 
nitase activity, the translational regulation of mt-aconitase 
may reflect a metabolic advantage for co-regulation of both 
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aconitases in response to cellular iron levels, perhaps to affect 
the catalytic turnover of citrate. Since citrate can bind iron 
and may serve as an intracellular iron transporter [48], both 
functions of IRP-1 might conspire to regulate intracellular 
iron transport. Clearly, this model calls for experimental test- 
ing. 
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